Latest Insider Transactions at Kindly Md, Inc. (KDLY)
This section provides a real-time view of insider transactions for Kindly Md, Inc. (KDLY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Kindly MD, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Kindly MD, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 22
2025
|
Jared Barrera Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,400
+22.34%
|
-
|
|
Sep 22
2025
|
Timothy Pickett Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
92,246
+12.43%
|
-
|
|
Sep 22
2025
|
Eric Stanton Weiss Director |
BUY
Grant, award, or other acquisition
|
Direct |
112,781
+50.0%
|
-
|
|
Sep 22
2025
|
Andrew John Creighton Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
601,503
+13.9%
|
-
|
|
Sep 22
2025
|
David F Bailey Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
751,879
+5.94%
|
-
|
|
Sep 22
2025
|
Amanda Fabiano Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,135,337
+47.5%
|
-
|
|
Sep 22
2025
|
Gregory Elias Xethalis Director |
BUY
Grant, award, or other acquisition
|
Direct |
112,781
+50.0%
|
-
|
|
Sep 22
2025
|
Perianne Boring Mc Nulty Director |
BUY
Grant, award, or other acquisition
|
Direct |
112,781
+50.0%
|
-
|
|
Sep 22
2025
|
Mark W Yusko Director |
BUY
Grant, award, or other acquisition
|
Direct |
112,781
+4.85%
|
-
|
|
Sep 22
2025
|
Tyler Matthew Evans Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
601,503
+16.65%
|
-
|
|
Sep 22
2025
|
Charles Phillip Blackburn Director |
BUY
Grant, award, or other acquisition
|
Direct |
112,781
+50.0%
|
-
|
|
Aug 14
2025
|
Tyler Matthew Evans Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,232,114
+48.08%
|
-
|
|
Aug 14
2025
|
Andrew John Creighton Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,232,114
+41.67%
|
-
|
|
Aug 14
2025
|
David F Bailey Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,160,572
+50.0%
|
-
|
|
May 12
2025
|
Timothy Pickett Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,780
+22.52%
|
$28,780
$1.61 P/Share
|
|
May 12
2025
|
Amy Powell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,838
+26.44%
|
$1,838
$1.61 P/Share
|
|
May 12
2025
|
Gary Seelhorst Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,838
+26.44%
|
$1,838
$1.61 P/Share
|
|
May 12
2025
|
Christian S. Robinson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,838
+26.44%
|
$1,838
$1.61 P/Share
|
|
Oct 24
2024
|
Amy Powell Director |
BUY
Grant, award, or other acquisition
|
Direct |
837
+50.0%
|
$837
$1.05 P/Share
|
|
Oct 24
2024
|
Adam Cox COO |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+11.0%
|
$9,000
$1.05 P/Share
|
|
Oct 24
2024
|
Gary Seelhorst Director |
BUY
Grant, award, or other acquisition
|
Direct |
837
+50.0%
|
$837
$1.05 P/Share
|
|
Oct 24
2024
|
Christian S. Robinson Director |
BUY
Grant, award, or other acquisition
|
Direct |
837
+50.0%
|
$837
$1.05 P/Share
|